glp-1 weight regain Drugs: Bridging Satiety, Nutrition, and Innovation – Kerry Health And Nutrition Institute Weight regain after stopping GLP-1

Macro trends - GLP1 and dual agonists (semaglutide, tirzepatide) have reshaped obesity treatment, but durability and fat redistribution on discontinuation remain clinical and commercial challenges

Taking an extra month or two to find your maintenance dose costs little compared to the frustration of regaining weight because you rushed the process

For some people, that works fine

Ji L., Jiang H., An P., et al., IBI362 (LY3305677), a WeeklyDose GLP1 and Glucagon Receptor Dual Agonist, in Chinese Adults With Overweight or Obesity: A Randomised, PlaceboControlled, Multiple Ascending Dose Phase 1b Study, EClinicalMedicine 39 (2021): 101088, 10.1016/j.eclinm.2021.101088

These lawsuits claim that both pharmaceutical companies didnt properly warn about the health risks of their GLP-1 drugs

But rather than cooling the space, it fueled a larger conversation about access, affordability, and pharmaceutical gatekeeping